BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18544684)

  • 1. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets.
    Cifuni SM; Wagner DD; Bergmeier W
    Blood; 2008 Sep; 112(5):1696-703. PubMed ID: 18544684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.
    Han X; Knauss EA; Fuente M; Li W; Conlon RA; LePage DF; Jiang W; Renna SA; McKenzie SE; Nieman MT
    J Thromb Haemost; 2024 Jun; 22(6):1715-1726. PubMed ID: 38508397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype analysis and clinical management in a large family with a novel truncating mutation in
    Desai A; Bergmeier W; Canault M; Alessi MC; Paul DS; Nurden P; Pillois X; Jy W; Ahn YS; Nurden AT
    Res Pract Thromb Haemost; 2017 Jul; 1(1):128-133. PubMed ID: 30046681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptors and glycoprotein VI cooperatively drive the platelet component in thromboelastography.
    Rudran T; Antoniak S; Flick MJ; Ginsberg MH; Wolberg AS; Bergmeier W; Lee RH
    J Thromb Haemost; 2023 Aug; 21(8):2236-2247. PubMed ID: 37068592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RasGRP2 Structure, Function and Genetic Variants in Platelet Pathophysiology.
    Canault M; Alessi MC
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates.
    Holinstat M; Preininger AM; Milne SB; Hudson WJ; Brown HA; Hamm HE
    Mol Pharmacol; 2009 Aug; 76(2):301-13. PubMed ID: 19483102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization of Rap1 GTPase activator CalDAG-GEFI is orchestrated by interaction of its atypical C1 domain with membrane phosphoinositides.
    Sarker M; Goliaei A; Golesi F; Poggi M; Cook AA; Khan MAI; Temple BR; Stefanini L; Canault M; Bergmeier W; Campbell SL
    J Thromb Haemost; 2020 Mar; 18(3):693-705. PubMed ID: 31758832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclical depressurization degranulates platelets in an agonist-free mechanism of platelet activation.
    Velasquez-Mao AJ; Velasquez M; Vandsburger MH
    PLoS One; 2022; 17(9):e0274178. PubMed ID: 36107866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icaritin Sensitizes Thrombin- and TxA2-Induced Platelet Activation and Promotes Hemostasis via Enhancing PLCγ2-PKC Signaling Pathways.
    Zhu Z; Luo Y; Liao H; Guo R; Hao D; Lu Z; Huang M; Sun C; Yao J; Wei N; Zeng K; Tu P; Zhang G
    Thromb Haemost; 2024 Feb; ():. PubMed ID: 38224965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASA3 is a critical inhibitor of RAP1-dependent platelet activation.
    Stefanini L; Paul DS; Robledo RF; Chan ER; Getz TM; Campbell RA; Kechele DO; Casari C; Piatt R; Caron KM; Mackman N; Weyrich AS; Parrott MC; Boulaftali Y; Adams MD; Peters LL; Bergmeier W
    J Clin Invest; 2015 Apr; 125(4):1419-32. PubMed ID: 25705885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAP1-GTPase signaling and platelet function.
    Stefanini L; Bergmeier W
    J Mol Med (Berl); 2016 Jan; 94(1):13-9. PubMed ID: 26423530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CalDAG-GEFI is at the nexus of calcium-dependent platelet activation.
    Stefanini L; Roden RC; Bergmeier W
    Blood; 2009 Sep; 114(12):2506-14. PubMed ID: 19628710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.
    Müller F; Mutch NJ; Schenk WA; Smith SA; Esterl L; Spronk HM; Schmidbauer S; Gahl WA; Morrissey JH; Renné T
    Cell; 2009 Dec; 139(6):1143-56. PubMed ID: 20005807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum.
    Uemura T; Lee SJ; Yasumura M; Takeuchi T; Yoshida T; Ra M; Taguchi R; Sakimura K; Mishina M
    Cell; 2010 Jun; 141(6):1068-79. PubMed ID: 20537373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rap1-GTP-interacting adaptor molecule (RIAM) is dispensable for platelet integrin activation and function in mice.
    Stritt S; Wolf K; Lorenz V; Vögtle T; Gupta S; Bösl MR; Nieswandt B
    Blood; 2015 Jan; 125(2):219-22. PubMed ID: 25336629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.
    Kennedy ME; Stamford AW; Chen X; Cox K; Cumming JN; Dockendorf MF; Egan M; Ereshefsky L; Hodgson RA; Hyde LA; Jhee S; Kleijn HJ; Kuvelkar R; Li W; Mattson BA; Mei H; Palcza J; Scott JD; Tanen M; Troyer MD; Tseng JL; Stone JA; Parker EM; Forman MS
    Sci Transl Med; 2016 Nov; 8(363):363ra150. PubMed ID: 27807285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial thrombosis--insidious, unpredictable and deadly.
    Jackson SP
    Nat Med; 2011 Nov; 17(11):1423-36. PubMed ID: 22064432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.
    Canault M; Ghalloussi D; Grosdidier C; Guinier M; Perret C; Chelghoum N; Germain M; Raslova H; Peiretti F; Morange PE; Saut N; Pillois X; Nurden AT; Cambien F; Pierres A; van den Berg TK; Kuijpers TW; Alessi MC; Tregouet DA
    J Exp Med; 2014 Jun; 211(7):1349-62. PubMed ID: 24958846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar.
    Aisiku O; Peters CG; De Ceunynck K; Ghosh CC; Dilks JR; Fustolo-Gunnink SF; Huang M; Dockendorff C; Parikh SM; Flaumenhaft R
    Blood; 2015 Mar; 125(12):1976-85. PubMed ID: 25587041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race.
    Edelstein LC; Simon LM; Lindsay CR; Kong X; Teruel-Montoya R; Tourdot BE; Chen ES; Ma L; Coughlin S; Nieman M; Holinstat M; Shaw CA; Bray PF
    Blood; 2014 Nov; 124(23):3450-8. PubMed ID: 25293779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.